Dr. Kodama joined Suntory Holdings Limited after graduating (1998) and completed master's degree (2000) at Kyushu University Department of Pharmaceutical Sciences. He obtained a PhD (Pharmaceutical Sciences) from Kyushu University in 2004. After pre-doctoral training at RIKEN and postdoctoral training at several university, he contributed to the industry-academic joint research at Hokkaido University as an associate professor and a project manager (2010-2016). He has been appointed Associate Professor at the Graduate School of Technology Management (MOT) of Ritsumeikan University, since 2016 to present. Since 2017 to present, he also has been appointed Vice Dean. He has been engaged in a variety of academic, business and projects management, especially in the field of Life Sciences. His areas of specialization are technology management, entrepreneurship, business development and bioinformatics.
As 2020 FFJ/Air Liquide Fellow, he will conduct a research project entitled “A comparative study of Japanese, US, and French regulation and science communication of AI used in medicine”. The research aims to find answers to the following questions with utilizing the scientific approaches;
- What are the main differences between the governmental policies used in France, Japan, and the USA in terms of utilizing AI in medical devices and therapeutic applications?
- How to increase AI adoption in the medical devices and therapeutic applications fields in France, Japan, and the USA?
- What is the general patient perspective about the AI used in healthcare and how the perspective differs from country to country (France, Japan, USA)?
His main publications are:1. Mohamed Farid*, Kota Kodama*, Teruyo Arato, Takashi Okazaki, Tetsuaki Oda, Hideko Ikeda, Shintaro Sengoku, Comparative Study of Functional Food Regulations in Japan and Globally, Global Journal of Health Science, Vol. 11, No. 6; 2019, 132-145
2. Wessam Atif, Mohamed Farid, Kota Kodama, Introducing an Online Consumer-Based Review Platform for Restaurant Hygiene, Global Journal of Health Science, Vol. 11, No. 2; 2019, 118-122
3. Tomohiro Makino, Shintaro Sengoku, Shuichi Ishida and Kota Kodama, Trends in interorganizational transactions in personalized medicine development, Drug Discovery Today, Volume 24, Issue 2, February 2019, Pages 364-370
4. Tomohiro Makino, Yeongjoo Lim and Kota Kodama, Strategic R&D transactions in personalized drug development, Drug Discovery Today. 2018 Jul;23(7):1334-1339.